Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Shares Issued (2020 - 2025)

Historic Shares Issued for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $17000.0.

  • Pulse Biosciences' Shares Issued fell 9997.14% to $17000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year decrease of 7639.52%. This contributed to the annual value of $59.6 million for FY2024, which is 30227.27% up from last year.
  • Per Pulse Biosciences' latest filing, its Shares Issued stood at $17000.0 for Q3 2025, which was down 9997.14% from -$12000.0 recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Shares Issued ranged from a high of $59.4 million in Q3 2024 and a low of -$72000.0 during Q3 2023
  • Over the past 5 years, Pulse Biosciences' median Shares Issued value was $334000.0 (recorded in 2022), while the average stood at $7.9 million.
  • As far as peak fluctuations go, Pulse Biosciences' Shares Issued crashed by 10083.84% in 2022, and later surged by 8253472.22% in 2024.
  • Quarter analysis of 5 years shows Pulse Biosciences' Shares Issued stood at $8.3 million in 2021, then plummeted by 100.35% to -$29000.0 in 2022, then tumbled by 148.28% to -$72000.0 in 2023, then surged by 82534.72% to $59.4 million in 2024, then plummeted by 99.97% to $17000.0 in 2025.
  • Its Shares Issued was $17000.0 in Q3 2025, compared to -$12000.0 in Q2 2025 and $14.1 million in Q1 2025.